GILD - Gilead to acquire CymaBay for $32.50/share in cash February, 12 2024 08:53 AM Gilead Sciences Inc. 2024-02-12 08:53:47 ET Gilead Sciences ( NASDAQ: GILD ) has agreed to acquire CymaBay Therapeutics ( NASDAQ: CBAY ) for a total equity value of $4.3B.... For further details see: Gilead to acquire CymaBay for $32.50/share in cash